Paola Grandi

GlaxoSmithKline (Germany)

Publishes on PARP inhibition in cancer therapy, Protein Degradation and Inhibitors, Multiple Myeloma Research and Treatments. 140 papers and 15.6k citations.

140Publications

15.6kTotal Citations

PARP inhibition in cancer therapy Protein Degradation and Inhibitors Multiple Myeloma Research and Treatments Biosimilars and Bioanalytical Methods Ubiquitin and proteasome pathways

Is this you? Claim your profile.

Add your photo, update your bio, and get notified when your ranking changes.

Top publicationsby citations

Functional organization of the yeast proteome by systematic analysis of protein complexes

Anne‐Claude Gavin, Markus Bösche, Roland Krause et al.|Nature|2002

Cited by 4.8kOpen Access

Proteome survey reveals modularity of the yeast cell machinery

Anne‐Claude Gavin, Patrick Aloy, Paola Grandi et al.|Nature|2006

Cited by 2.6k

Catalytic in vivo protein knockdown by small-molecule PROTACs

Daniel P. Bondeson, Alina Mares, Ian E. Smith et al.|Nature Chemical Biology|2015

Cited by 1.3kOpen Access

Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes

Marcus Bantscheff, Carsten Hopf, Mikhail M. Savitski et al.|Nature Biotechnology|2011

Cited by 662

90S Pre-Ribosomes Include the 35S Pre-rRNA, the U3 snoRNP, and 40S Subunit Processing Factors but Predominantly Lack 60S Synthesis Factors

Paola Grandi, Vladimir Rybin, Jochen Baßler et al.|Molecular Cell|2002

Cited by 451Open Access